Compare PX & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PX | CLOV |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2021 | N/A |
| Metric | PX | CLOV |
|---|---|---|
| Price | $9.40 | $2.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $15.70 | $4.23 |
| AVG Volume (30 Days) | 571.2K | ★ 7.8M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | ★ 35.89 | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | $301,314,000.00 | ★ $1,773,564,000.00 |
| Revenue This Year | $4.31 | $40.52 |
| Revenue Next Year | $18.45 | $31.46 |
| P/E Ratio | $68.46 | ★ N/A |
| Revenue Growth | 9.77 | ★ 32.15 |
| 52 Week Low | $8.68 | $2.12 |
| 52 Week High | $14.28 | $4.87 |
| Indicator | PX | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 42.92 |
| Support Level | $8.68 | $2.48 |
| Resistance Level | $9.51 | $2.44 |
| Average True Range (ATR) | 0.37 | 0.11 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 34.62 | 59.43 |
P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.